Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately. (See "Society guideline links: Primary ovarian insufficiency" and "Society guideline links: Osteoporosis" and "Society guideline links: Breast cancer" and "Society guideline links: Primary prevention of cardiovascular disease".)
International
●Endocrine Society (ES): Pharmacological management of osteoporosis in postmenopausal women, update (2020)
•ES: Pharmacological management of osteoporosis in postmenopausal women (2019)
●NAMS: Position statement on the genitourinary syndrome of menopause (2020)
●NAMS: Hormone therapy position statement (2017)
●Revised global consensus statement on menopausal hormone therapy (2016)
●ES: Clinical practice guideline for the treatment of symptoms of the menopause (2015)
●NAMS: Position statement for the nonhormonal management of menopause-associated vasomotor symptoms (2015)
●NAMS: Statement on continuing use of systemic hormone therapy after age 65 (2015)
●ES: Clinical practice guideline on androgen therapy in women – A reappraisal (2014)
●ISSWSH and NAMS: Genitourinary syndrome of menopause – New terminology for vulvovaginal atrophy (2014)
●NAMS: Recommendations for clinical care of midlife women (2014)
●IMS: Recommendations for the management of postmenopausal vaginal atrophy (2010)
Canada
●SOGC: Canadian consensus on female nutrition – Adolescence, reproduction, menopause, and beyond (2016)
●SOGC: Clinical practice guideline on managing menopause (2014)
●SOGC: Clinical practice guideline on osteoporosis in menopause (2014)
United States
●American College of Obstetricians and Gynecologists (ACOG): Committee opinion on hormone therapy and heart disease (2013, reaffirmed 2020)
●ACOG and the American Society for Reproductive Medicine (ASRM): Committee opinion on compounded bioidentical menopausal hormone therapy (2012, reaffirmed 2020)
●ACOG: Committee opinion on postmenopausal estrogen therapy – Route of administration and risk of venous thromboembolism (2013, reaffirmed 2017)
●ACOG: Practice bulletin on the management of menopausal symptoms (2014)
●SGS: Vaginal estrogen for genitourinary syndrome of menopause – A systematic review (2014)
Europe
●European Menopause and Andropause Society (EMAS): Clinical guides
United Kingdom
●British Menopause Society (BMS): Consensus statements
●National Institute for Health and Care Excellence (NICE): Guideline on menopause – Diagnosis and management (2015, updated 2019)
●NICE: Quality standard on menopause (2017)
Japan
●[In Japanese] Japan Society for Menopause and Women's Health (JMWH) and Japanese Obstetrics and Gynecology Society (JOGS): Hormone replacement therapy guideline (2012)